Arrays Come of Age

Premium

Just a couple of years ago, you couldn’t pass through a crowded hallway at an array conference without hearing that dreaded word: reproducibility. Now, it seems that arrays are finally coming into their own — according to a GenomeWeb survey sent out to microarray users in February, fewer than a third of respondents thought reproducibility was much of a problem. Cost, though, remains prohibitive, according to our survey data. Below are some of the highlights of our microarray snapshot.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The World Health Organization has announced the members of its gene-editing committee, according to NPR.

DARPA is working on developing algorithms that gauge the credibility of research findings, Wired reports.

The American Society of Breast Surgeons recommends all women diagnosed with breast cancer be offered genetic testing, the Washington Post says.

In Science this week: comparison of modern, historical rabbit exomes uncovers parallel evolution after myxoma virus exposure; and more.